Arcturus Therapeutics Holdings Inc.

ARCT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$81-$30$9-$204
Dep. & Amort.$4$3$2$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$38$35$31$29
Change in WC-$21$7-$13$33
Other Non-Cash$0-$33$3$6
Operating Cash Flow-$60-$18$32-$135
Investing Activities
PP&E Inv.-$1-$3-$8-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$3-$8-$3
Financing Activities
Debt Repay.$0-$27-$5$47
Stock Issued$1$1$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5$3$2$1
Financing Cash Flow$5-$24-$3$48
Forex Effect$0$0$0$0
Net Chg. in Cash-$55-$45$21-$90
Supplemental Information
Beg. Cash$349$394$373$463
End Cash$294$349$394$373
Free Cash Flow-$60-$21$24-$138
Arcturus Therapeutics Holdings Inc. (ARCT) Financial Statements & Key Stats | AlphaPilot